Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy.

Created on 17 Nov 2026

Authors

Jamey Cutts, Christopher Kramer

Published in

Cardiology clinics. Volume 45. Issue 1. Pages 75-86.

Abstract

Hypertrophic cardiomyopathy (HCM) is characterized by pathologic hypertrophy in the absence of a potentially causative disease process and carries increased risk of heart failure, atrial fibrillation, and sudden cardiac death. Synergistic use of multi-modal imaging is pivotal and necessary in the diagnosis and management of patients with, or at risk for, HCM. Echocardiography, cardiac MR, and cardiac computed tomography each have important roles and limitations in assessing the morphologic changes responsible for symptoms and morbidity in HCM. In this article, we will explore these modalities and their roles in evaluating HCM.

PMID:
43039638
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement